Home › J&J Hepatitis C Drug Wins U.S. Approval as Therapy With Sovaldi
 

Keywords :   


J&J Hepatitis C Drug Wins U.S. Approval as Therapy With Sovaldi

2014-11-06 15:21:29| Food - Topix.net

Johnson & Johnson won U.S. approval for its hepatitis C drug Olysio to be used in combination with Gilead Sciences Inc.'s Sovaldi, making it the second all-oral treatment available for the most common form of the virus. The Food and Drug Administration cleared the once-daily treatment for patients with hepatitis C genotype 1, J&J said yesterday in a statement.

Tags: with drug approval therapy

Category:Food and Related Products

Latest from this category

All news
»
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
27.09Summary for Remnants of John (EP5/EP102024)
27.09Tropical Storm Joyce Graphics
More »